Philips appoints Julia Strandberg as Chief Business Leader of the Connected Care businesses
13 Mars 2023 - 08:00AM
GlobeNewswire Inc.
Philips appoints Julia Strandberg as Chief Business Leader of the
Connected Care businesses
March 13, 2023
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the appointment of Julia Strandberg as the Chief Business
Leader of its Connected Care businesses, effective April 24, 2023.
Ms. Strandberg will become a member of Philips’ Executive Committee
reporting to Philips CEO Roy Jakobs. As of April 1, 2023, Philips’
Connected Care businesses will comprise the Monitoring, Sleep &
Respiratory Care and Enterprise Informatics businesses.
Ms. Strandberg (American, 1974) joins Philips from Pear
Therapeutics, where she served as the Chief Commercial Officer
leading the commercial team that built, launched and grew their
prescription digital therapeutics offering. Prior to this, Ms.
Strandberg led a healthcare business consulting firm focused on
driving client growth, and before this, she led Medtronic’s global
Health Informatics and Monitoring business, and was the global
marketing leader for the Patient Monitoring business within
Covidien’s Respiratory & Monitoring group, which was acquired
by Medtronic. Ms. Strandberg started her career at 3M, where she
worked across a number of roles at the company.
“On behalf of Philips’ Executive Committee, I am delighted to
announce that Julia Strandberg will join Philips as our new Chief
Business Leader of the Connected Care businesses and member of the
Executive Committee,” said Roy Jakobs, CEO of Royal Philips. “Julia
brings deep, multi-disciplinary expertise, including in informatics
and monitoring, to Philips. Passionate about improving the
healthcare experience for patients and providers across care
settings, Julia understands how to deliver in the global healthcare
ecosystem and adds extensive experience in developing and
commercializing medical technologies.”
Ms. Strandberg succeeds Dan Leonard, who took on the role of
Chief Business Leader Connected Care ad interim when Roy Jakobs
became CEO in October, 2022.
Philips’ strong brand and compelling purpose appeal to and
attract talent, and the company has therefore continued to
strengthen the organization with new health technology talent,
including seasoned leaders with deep expertise. Ms. Strandberg ’s
appointment to Philips’ Executive Committee builds on the recent
appointments of Wim Appelo as Philips’ Chief Operations Officer and
Steve C. de Baca as Philips’ Chief Patient Safety & Quality
Officer, as well as the promotion of Jeff DiLullo to Philips’ Chief
Market Leader of North America.
Additional information on Philips’ Executive Committee can be
found here.
For further information, please contact:
Ben ZwirsPhilips Global Press OfficeTel.: +31 615213446E-mail:
ben.zwirs@philips.com
Derya GuzelPhilips Investor RelationsTel.: +31 20 59
77055E-mail: derya.guzel@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and well-being through meaningful
innovation. Philips’ patient- and people-centric innovation
leverages advanced technology and deep clinical and consumer
insights to deliver personal health solutions for consumers and
professional health solutions for healthcare providers and their
patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging,
ultrasound, image-guided therapy, monitoring and enterprise
informatics, as well as in personal health. Philips generated 2022
sales of EUR 17.8 billion and employs approximately 77,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
Forward-looking statementsThis release contains
certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and
certain of the plans and objectives of Philips with respect to
these items. Examples of forward-looking statements include
statements made about the strategy, estimates of sales growth,
future EBITA, future developments in Philips’ organic business and
the completion of acquisitions and divestments. By their nature,
these statements involve risk and uncertainty because they relate
to future events and circumstances and there are many factors that
could cause actual results and developments to differ materially
from those expressed or implied by these statements.
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Mai 2023 à Juin 2023
Koninklijke Philips NV (EU:PHIA)
Graphique Historique de l'Action
De Juin 2022 à Juin 2023